Yumanity Secures $45,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=534383f0-a2f4-44c4-a4e9-a7125624f98f - Date
2/11/2016 - Company Name
Yumanity - Mailing Address
790 Memorial Drive Cambridge, MA 02139 USA - Company Description
Yumanity Therapeutics is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. - Website
http://www.yumanity.com - Transaction Type
Venture Equity - Transaction Amount
$45,000,000 - Transaction Round
Series A - Proceeds Purposes
The Series A financing will accelerate efforts to advance Yumanity Therapeutics’ proprietary platforms aimed at identifying novel therapies to treat neurodegenerative diseases caused by protein misfolding including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. - M&A Terms
- Venture Investor
Fidelity Management & Research Company - Venture Investor
Redmile Group - Venture Investor
Alexandria Venture Investments - Venture Investor
Biogen Idec - Venture Investor
Dolby Family Ventures
